These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17161073)

  • 1. Evaluation of dyslipidemia in the emergency department: impact of cholesterol testing on subsequent therapy.
    Blomkalns AL; O'Connell EM; Eady CE; Lindsell CJ; Gibler WB
    Am Heart J; 2006 Dec; 152(6):1182-6. PubMed ID: 17161073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP study: a randomized controlled trial.
    Grover SA; Lowensteyn I; Joseph L; Kaouache M; Marchand S; Coupal L; Boudreau G;
    Arch Intern Med; 2007 Nov; 167(21):2296-303. PubMed ID: 18039987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium.
    Goff DC; Bertoni AG; Kramer H; Bonds D; Blumenthal RS; Tsai MY; Psaty BM
    Circulation; 2006 Feb; 113(5):647-56. PubMed ID: 16461837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of a fenofibrate 145-mg nanoparticle tablet formulation compared with the standard 160-mg tablet in patients with coronary heart disease and dyslipidemia.
    Maciejewski S; Hilleman D
    Pharmacotherapy; 2008 May; 28(5):570-5. PubMed ID: 18447655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV; Frick KD; Wade A; Simko R; Burge R
    Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines database).
    Albert NM; Birtcher KK; Cannon CP; Goff DC; Mulgund J; Liang L; Fonarow GC
    Am J Cardiol; 2008 May; 101(9):1242-6. PubMed ID: 18435951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-year evaluation of electronic medical record flag alerts for patients warranting secondary prevention of coronary heart disease.
    Whitley HP; Fermo JD; Chumney EC
    Pharmacotherapy; 2006 May; 26(5):682-8. PubMed ID: 16637797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary heart disease and dyslipidemia: a cross-sectional evaluation of prevalence, current treatment, and clinical control in a large cohort of Spanish high-risk patients: the PRINCEPS study.
    de Rojas FD; De Frutos T; Ponte A; Chacón JM; Vitale GC;
    Prev Cardiol; 2009; 12(2):65-71. PubMed ID: 19476579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and treatment of dyslipidemia in Canadian primary care: a retrospective cohort analysis.
    Petrella RJ; Merikle E; Jones J
    Clin Ther; 2007 Apr; 29(4):742-50. PubMed ID: 17617298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of cholesterol screening and management with respect to the National Cholesterol Education's Third Adult Treatment Panel (ATPIII) guideline in primary care practices in North Carolina.
    Bertoni AG; Bonds DE; Steffes S; Jackson E; Crago L; Balasubramanyam A; Chen H; Goff DC
    Am Heart J; 2006 Oct; 152(4):785-92. PubMed ID: 16996859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002.
    Keevil JG; Cullen MW; Gangnon R; McBride PE; Stein JH
    Circulation; 2007 Mar; 115(11):1363-70. PubMed ID: 17353444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does concordance with guideline triage recommendations affect clinical care of patients with possible acute coronary syndrome?
    Katz DA; Dawson J; Beshansky JR; Rahko PS; Aufderheide TP; Bogner M; Tighouart H; Selker HP
    Med Decis Making; 2007; 27(4):423-37. PubMed ID: 17641142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels.
    Ali F; Laurin MY; Larivière C; Tremblay D; Cloutier D
    Can J Clin Pharmacol; 2003; 10(3):101-6. PubMed ID: 14506507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the impact of adding C-reactive protein as a criterion for lipid lowering treatment in the United States.
    Woloshin S; Schwartz LM; Kerin K; Welch HG
    J Gen Intern Med; 2007 Feb; 22(2):197-204. PubMed ID: 17356986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
    Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
    Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen study).
    May HT; Anderson JL; Pearson RR; Jensen JR; Horne BD; Lavasani F; Yannicelli HD; Muhlestein JB
    Am J Cardiol; 2008 Feb; 101(4):486-9. PubMed ID: 18312763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thailand diabetes registry project: current status of dyslipidemia in Thai diabetic patients.
    Pratipanawatr T; Rawdaree P; Chetthakul T; Bunnag P; Ngarmukos C; Benjasuratwong Y; Leelawatana R; Kosachunhanun N; Plengvidhya N; Deerochanawong C; Suwanwalaikorn S; Krittiyawong S; Mongkolsomlit S; Komoltri C
    J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S60-5. PubMed ID: 17715835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergency Department education improves patient knowledge of coronary artery disease risk factors but not the accuracy of their own risk perception.
    Williams A; Lindsell C; Rue L; Blomkalns A
    Prev Med; 2007 Jun; 44(6):520-5. PubMed ID: 17336373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyslipidemia control in indigent patients receiving medication assistance compared with insured patients.
    Marrs JC; Saseen JJ
    Pharmacotherapy; 2008 May; 28(5):562-9. PubMed ID: 18447654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.